UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NHS
6276
Neuberger High Yield Strategies Fund Inc
NHS
$255M
| $86.2K | ﹤0.01% |
11,025
-6,549
| -37% | -$52.2K |
|
6277
Identive
INVE
$61.9M
| $86K | ﹤0.01% |
20,000
+17,984
| +892% | +$85.5K |
|
6278
MBIA
MBI
$260M
| $86K | ﹤0.01% |
15,656
-47,501
| -75% | -$285K |
|
6279
CytomX Therapeutics
CTMX
$753M
| $85.8K | ﹤0.01% |
70,368
+49,875
| +243% | +$99.3K |
|
6280
iBio
IBIO
$70M
| $85.8K | ﹤0.01% |
40,669
+38,792
| +2,067% | +$83.4K |
|
6281
Talkspace
TALK
$874M
| $85.8K | ﹤0.01% |
37,295
-275,208
| -88% | -$791K |
|
6282
Caledonia Mining Corp
CMCL
$420M
| $85.8K | ﹤0.01% |
8,823
-11,604
| -57% | -$120K |
|
|
ACLC
6283
American Century Large Cap Equity ETF
ACLC
$324M
| $85.6K | ﹤0.01% |
+1,270
| New | +$82.9K |
|
6284
Alta Equipment Group
ALTG
$244M
| $85.6K | ﹤0.01% |
10,641
-46,811
| -81% | -$474K |
|
6285
Lifezone Metals
LZM
$370M
| $85.4K | ﹤0.01% |
11,123
+9,143
| +462% | +$71.3K |
|
|
SPE
6286
Special Opportunities Fund
SPE
$144M
| $85.1K | ﹤0.01% |
6,807
-817
| -11% | -$9.94K |
|
6287
Algoma Steel
ASTL
$431M
| $85K | ﹤0.01% |
12,219
-663
| -5% | -$5.12K |
|
6288
CALL
MacroGenics
MGNX
$257M
| $85K | ﹤0.01% |
+20,000
| New | +$195K |
|
|
KRKR
6289
36Kr Holdings
KRKR
$6.26M
| $85K | ﹤0.01% |
12,839
+12,834
| +256,680% | +$98.8K |
|
6290
Twin Disc
TWIN
$348M
| $84.6K | ﹤0.01% |
7,185
+5,399
| +302% | +$80K |
|
6291
SunCar Technology Group
SDA
$86.7M
| $84.4K | ﹤0.01% |
9,269
+7,291
| +369% | +$56.7K |
|
6292
ProShares UltraPro Short Dow 30
SDOW
$137M
| $84.4K | ﹤0.01% |
1,269
+537
| +73% | +$36.8K |
|
6293
Flexible Solutions
FSI
$64.1M
| $84.1K | ﹤0.01% |
48,065
-2,242
| -4% | -$4.63K |
|
6294
Unisys
UIS
$217M
| $84K | ﹤0.01% |
20,346
-46,417
| -70% | -$227K |
|
6295
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
| $83.8K | ﹤0.01% |
1,939
+1,848
| +2,031% | +$81.3K |
|
6296
BARK
BARK
$101M
| $83.8K | ﹤0.01% |
2,315
-4,517
| -66% | -$116K |
|
6297
PUT
ICICI Bank
IBN
$108B
| $83.5K | ﹤0.01% |
2,900
-1,000
| -26% | -$26.8K |
|
6298
MicroSectors Gold 3x Leveraged ETN
SHNY
$9.66M
| $83.3K | ﹤0.01% |
+24,600
| New | +$88.5K |
|
6299
Vident US Bond Strategy ETF
VBND
$526M
| $83.3K | ﹤0.01% |
+1,927
| New | +$83.2K |
|
6300
GraniteShares Gold Shares
BAR
$1.46B
| $83.3K | ﹤0.01% |
3,628
+3,173
| +697% | +$73.3K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.